


















































Pursuit of cell therapy
Mineko FUJIMIYA
Department of Anatomy (II), Sapporo Medical University School of Medicine.
ABSTRACT
We focus on the therapeutic strategies for diabetic complications and Alzheimer’s dementia by autologous bone 
marrow mesenchymal stem cell (MSC) transplantation. In addition to the clinical research, basic research for the 
mechanism why MSCs can recover tissue damage is important. Stromal (interstitial) cells in every organs support 
parenchymal cells and maintain their functions. We found that stromal cell damage primarily occurs in diabetes and 
subsequently causes parenchymal cell damage. Our concept to treat diseases by MSCs is to normalize stromal cells by 
transplantation of their progenitor MSCs.
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